Phenylephrine Lawsuit Investigation: Decongestants Are Ineffective, FDA Panel Says

Last Updated on September 14, 2023

Comments |

At A Glance

This Alert Affects:
Anyone who purchased over-the-counter (OTC) cold, flu and allergy medications containing a decongestant known as phenylephrine.
What’s Going On?
In September 2023, a panel of FDA advisors declared that phenylephrine, a popular nasal decongestant found in many OTC cold and allergy medications, doesn’t work. Attorneys are now investigating whether consumers who purchased these products could take action via a class action lawsuit.
How Could a Class Action Lawsuit Help?
If filed and successful, a class action lawsuit could give consumers the chance to get back some of the money they spent on the medicine.
What You Can Do
If you purchased an OTC nasal decongestant medicine containing phenylephrine, help this investigation by filling out the form on this page. You may be able to get a class action lawsuit started.

The information submitted on this page will be forwarded to Milberg Coleman Bryson Phillips Grossman, PLLC who has sponsored this investigation.

Contact Us